Lead. Getting more sleep may do more than boost alertness — it could fundamentally lower your risk of developing epilepsy, according to a major new study that combines human genetic analysis with laboratory experiments in stem cells and mice. Researchers from Tianjin Medical University and Huanhu Hospital in China found that genetically predicted longer sleep duration is causally associated with a reduced risk of epilepsy, and they identified a specific calcium channel gene variant — CACNA1A rs2228130 — that helps explain why.
The study, published July 20 in Neuromolecular Medicine, is the first to pair large-scale Mendelian randomization — a genetic technique that mimics randomized controlled trials — with functional validation of a specific epilepsy-risk variant that links sleep and seizure susceptibility. The findings suggest that sleep duration is not just a consequence of epilepsy but may play a direct, causal role in its development.
What they found. The researchers analyzed publicly available genome-wide association study (GWAS) data from European populations, using sleep trait data from the UK Biobank (n = 446,118 for sleep duration; n = 462,525 for insomnia) and epilepsy data from the International League Against Epilepsy consortium (n = 15,212 cases and 29,677 controls). They applied three complementary Mendelian randomization methods — inverse-variance weighted, MR-Egger, and weighted median — to test whether sleep traits causally influence epilepsy risk.
The results were clear. Genetically instrumented longer sleep duration was significantly associated with lower epilepsy risk (odds ratio = 0.9937, p < 1 x 10^-5). Every additional hour of genetically predicted sleep corresponded to a roughly 0.6 percent reduction in epilepsy odds. The finding was consistent across all three MR methods, strengthening confidence in a genuine causal relationship.
The insomnia analysis, by contrast, was undermined by extreme heterogeneity (Cochran’s Q = 9352.91), making those results unreliable. The authors concluded that the insomnia instruments were too pleiotropic — meaning the genetic variants linked to insomnia affected many biological pathways beyond sleep — to support a valid causal estimate.
To understand the biological mechanisms underlying the sleep-epilepsy link, the team then performed gene-level enrichment analysis using MAGMA and DEPICT tools. Surprisingly, the epilepsy-associated genes converged on broad biological regulation processes rather than specifically on GABAergic synapse or circadian rhythm pathways, as some earlier work had suggested. This suggests the connection between sleep and epilepsy involves a wider network of regulatory mechanisms than previously appreciated.
The researchers then focused on a specific variant in the CACNA1A gene — rs2228130 — which encodes a subunit of a voltage-gated calcium channel critical for neurotransmitter release. Using CRISPR-ABE base editing in human induced pluripotent stem cells (iPSCs), they introduced this variant into neurons and measured its functional effects. The edited neurons showed impaired inhibitory synaptic transmission — a key deficit that can tip neural networks toward hyperexcitability and seizure activity.
In a complementary experiment, the team generated knock-in mice carrying the same CACNA1A variant. These mice displayed more frequent epileptiform discharges on electroencephalography, reduced NREM sleep duration, decreased slow-wave activity during sleep, and altered expression of circadian rhythm-related genes. The variant essentially created a double burden: it both disrupted sleep architecture and increased seizure susceptibility.
Importantly, the researchers tested whether some of these abnormalities could be reversed. Both pharmacological interventions and sleep-based manipulations partially ameliorated the electrophysiological and behavioral deficits in the knock-in mice, suggesting that targeting sleep quality might offer a therapeutic avenue in individuals carrying epilepsy-risk variants.
Why it matters. Epilepsy affects roughly 50 million people worldwide, making it one of the most common neurological disorders. While clinicians have long observed that people with epilepsy often have poor sleep, the direction of causality has been debated. Does epilepsy disrupt sleep, or does poor sleep increase the risk of developing epilepsy? This study provides the strongest genetic evidence to date that the arrow points both ways and that sleep duration sits upstream as a causal risk factor.
The identification of CACNA1A rs2228130 as a functional variant linking sleep disturbance to seizure susceptibility opens new possibilities. Calcium channel dysfunction is a known mechanism in several neurological conditions, and existing drugs targeting these channels could potentially be repurposed. More broadly, the findings add to a growing body of evidence that prioritizing sleep — particularly sufficient duration and deep slow-wave sleep — may be an accessible, low-cost strategy for reducing neurological risk.
The study also demonstrates the value of a multi-layered approach. Mendelian randomization alone can suggest causality but cannot identify mechanism. By following up with gene editing in human neurons and behavioral experiments in mice, the researchers were able to trace a path from a single nucleotide change all the way to altered brain rhythms and seizures.
Limits. Several caveats apply. The Mendelian randomization analysis was restricted to European-ancestry populations, and the results may not generalize to other ethnic groups. The effect size was modest — an odds ratio of 0.9937 — meaning that sleep duration alone explains only a small fraction of epilepsy risk at the population level. The insomnia analysis was inconclusive due to high instrumental variable heterogeneity, leaving the relationship between insomnia and epilepsy unresolved. While the CACNA1A variant showed clear functional effects, it is one of many genetic variants that contribute to epilepsy risk, and the broader enrichment analysis pointed to diffuse biological regulation rather than a single pathway. Finally, the mouse experiments, while informative, are an imperfect model of human sleep and seizure disorders.
Bottom line. Longer sleep duration is causally linked to lower epilepsy risk through mechanisms involving CACNA1A-mediated inhibitory synaptic dysfunction. The findings support sleep optimization as a potential modifiable factor in epilepsy prevention and highlight calcium channel biology as a promising therapeutic target. While the absolute risk reduction is small, the population-level impact could be meaningful given that sleep duration is a behavior almost everyone can modify.
Source. Xun Li, Yuying Hou, Yanping Ren, Wei Yue. Causal Association Between Sleep Traits and Epilepsy Risk: A Mendelian Randomization Study With Functional Validation of the CACNA1A Variant. Neuromolecular Med. 2026 Jul 20;28(1):43. DOI: 10.1007/s12017-026-08943-8. PMID: 42474867.